Arrowhead Pharmaceuticals, Inc.

NasdaqGS:ARWR Stock Report

Market Cap: US$2.4b

Arrowhead Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ARWR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Apr 24SellUS$168,180James HamiltonIndividual6,000US$28.03
20 Mar 24BuyUS$82,990Hongbo LuIndividual3,000US$28.00
06 Mar 24SellUS$1,407,600Kenneth MyszkowskiIndividual40,000US$35.19
20 Nov 23SellUS$567,315Javier San MartinIndividual19,700US$29.00
28 Sep 23SellUS$40,812Victoria VakienerIndividual1,550US$26.33

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ARWR?
Owner TypeNumber of SharesOwnership Percentage
State or Government75,2480.0605%
Individual Insiders4,889,6523.93%
Hedge Funds8,888,8887.15%
General Public19,375,08615.6%
Institutions91,086,40073.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16%.


Top Shareholders

Top 25 shareholders own 68.21% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.6%
BlackRock, Inc.
15,683,206US$304.6m2.19%0.01%
9.83%
The Vanguard Group, Inc.
12,214,101US$237.2m-1.53%no data
7.15%
Avoro Capital Advisors LLC
8,888,888US$172.6m3.9%2.26%
5.48%
FMR LLC
6,810,929US$132.3m6.52%0.01%
4.7%
State Street Global Advisors, Inc.
5,837,762US$113.4m-11%no data
3.33%
Slate Path Capital LP
4,139,000US$80.4m0%1.64%
2.99%
Christopher Anzalone
3,715,048US$72.1m0%no data
2.57%
Artal Group S.A.
3,189,389US$61.9m5.03%1.52%
2.36%
Geode Capital Management, LLC
2,937,948US$57.1m6.65%no data
2.12%
UBS Asset Management AG
2,638,458US$51.2m90.5%0.01%
2.12%
T. Rowe Price Group, Inc.
2,634,731US$51.2m44%no data
1.49%
JP Morgan Asset Management
1,857,017US$36.1m-21.5%no data
1.31%
Morgan Stanley, Investment Banking and Brokerage Investments
1,630,188US$31.7m74.2%no data
1.28%
Norges Bank Investment Management
1,585,320US$30.8m19.9%no data
1.07%
Credit Suisse Asset Management (Switzerland) Ltd.
1,332,032US$25.9m0%0.02%
1.06%
Northern Trust Global Investments
1,322,718US$25.7m1.7%no data
0.9%
Goldman Sachs Group, Investment Banking and Securities Investments
1,122,960US$21.8m28.2%0.01%
0.87%
BNY Asset Management
1,076,940US$20.9m2.79%no data
0.8%
Charles Schwab Investment Management, Inc.
994,361US$19.3m1.08%no data
0.76%
Citadel Advisors LLC
948,444US$18.4m27.8%0.02%
0.76%
Rokos Capital Management LLP
939,984US$18.3m-23.5%0.44%
0.73%
Aquilo Capital Management, LLC
908,474US$17.6m0%17.95%
0.66%
Woodline Partners LP
821,518US$16.0m47.9%0.15%
0.66%
Western Financial Corporation
820,239US$15.9m0%9.64%
0.6%
Pictet Asset Management Limited
743,684US$14.4m-39.3%0.01%